thiazoles has been researched along with Edema in 172 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (17.44) | 18.7374 |
| 1990's | 33 (19.19) | 18.2507 |
| 2000's | 54 (31.40) | 29.6817 |
| 2010's | 44 (25.58) | 24.3611 |
| 2020's | 11 (6.40) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aziz, SA; El-Koussi, NA; Gomaa, HAM; Lan, P; Salem, OIA; Taher, ES; Youssif, BGM | 1 |
| Dao, EA; George, SJ; Heberton, MM; Kovitz, CA; Pacha, O; Patel, AB; Phillips, RM | 1 |
| Abdelmoez, AAB; Abdu-Allah, HHM; El-Awady, R; El-Shorbagi, AA; Tarazi, H | 1 |
| Abdel-Moty, SG; Abou-Ghadir, OMF; Ali, AY; Maghraby, MT; Salem, OIA | 1 |
| Ahmed, A; Bari, A; Molvi, KI; Patel, HM; Ullah, R | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Jacob P, J; Manju, SL | 1 |
| Guan, LP; He, LY; Peng, DX; Wang, SH; Zhang, SS | 1 |
| Kumar, G; Singh, NP | 1 |
| Abd-Allah, WH; Aboregela, AM; El-Behairy, MF; Lan, P; Marzouk, AA; Shaykoon, MSA; Taher, ES | 1 |
| Abdel-Aziz, SA; Asaad, GF; El-Koussi, NA; Gomaa, HAM; Lan, P; Taher, ES; Youssif, BGM | 1 |
| Aerts, O; Kerre, S | 1 |
| Britti, D; Crupi, R; Cuzzocrea, S; Di Paola, R; Evangelista, M; Fusco, R; Gugliandolo, E; Impellizzeri, D; Morittu, VM; Schievano, C | 1 |
| Alves, D; de Oliveira, RL; Luchese, C; Pinz, MP; Reis, AS; Roehrs, JA; Sacramento, MD; Vogt, AG; Voss, GT; Wilhelm, EA | 1 |
| Abdelazeem, AH; El-Moghazy, SM; El-Saadi, MT; Omar, HA; Said, EG; Youssif, BGM | 1 |
| Karnik, KS; Lokwani, DK; Sarkate, AP; Shinde, DB | 1 |
| Bhole, RP; Chitlange, SS; Tapkir, AS | 1 |
| Fikry, EM; Hasan, WA; Mohamed, EG | 1 |
| Azouz, AA; Bakr, RB; Ghoneim, AA | 1 |
| Das, RD; Nivsarkar, M; Panchal, NB; Sagar, SR; Singh, DP; Sudarsanam, V; Vasu, KK | 1 |
| Aggarwal, R; Gupta, GK; Kaushik, D; Kaushik, P; Kumar, S | 1 |
| Aneja, KR; Chandak, N; Jain, S; Kaushik, D; Kaushik, P; Kumar, P; Sharma, C; Sharma, PK; Varshney, P | 1 |
| Aljahdali, M; El-Gaby, MS; Helal, MH; Salem, MA | 1 |
| D'Erme, M; Galeone, M; Gola, M; Milanesi, N; Simonacci, F | 1 |
| Bedi, PM; Jain, NK; Khurana, S | 2 |
| Alves, MP; Fernandes, RS; Ianiski, FR; Luchese, C; Villalba, BT; Wilhelm, EA | 1 |
| Kaushik, D; Kaushik, P; Khloya, P; Kumar, S; Sharma, PK; Surain, P | 1 |
| Abbas, NS; Mohareb, RM; Zaki, MY | 1 |
| Ertan, M; Kazkayasi, I; Okay, G; Ozadali-Sari, K; Sarigol, D; Somuncuoglu, EI; Tel, BC; Tozkoparan, B; Unsal-Tan, O; Uzgoren-Baran, A | 1 |
| Abdelazeem, AH; Maghrabi, IA; Salama, SA | 1 |
| Bernardes, CP; Cintra, AC; de Oliveira, F; Faccioli, LH; Mamede, CC; Menaldo, DL; Sampaio, SV; Stanziola, L; Zoccal, KF | 1 |
| Aragon-Martínez, OH; García-Ávalos, Y; Isiordia-Espinoza, MA; Orozco-Solís, M; Pichardo-Ramírez, C; Tobías-Azúa, F; Zapata-Morales, JR | 1 |
| Abdallah, MA; Amin, MM; Farghaly, TA; Masaret, GS; Muhammad, ZA | 1 |
| MAGYAR, I | 1 |
| Shinomol, GK | 1 |
| Chaviara, AT; Hadjipavlou-Litina, D; Pontiki, E | 1 |
| Agrawal, SK; Gupta, PP; Rani, R; Saxena, AK; Sondhi, SM | 1 |
| Chaturvedi, SC; Pancholi, SS; Sharma, RN; Vasu, KK; Xavier, FP | 1 |
| Aubier, M; Bader, T; Chanez, P; Charpin, D; de Blay, F; Garcia, G; Gineste, P; Hermine, O; Humbert, M; Leroyer, C; Magnan, A; Moussy, A; Pison, C; Prud'homme, A; Purohit, A; Tunon-de-Lara, JM; Vachier, I | 1 |
| Ah, YC; Bae, JH; Choi, JK; Choi, YK; Ki, HM | 1 |
| Abdel-Moty, SG; Abou-Ghadir, OM; Hussein, MA; Kafafy, AH | 1 |
| Arunachalam, PN; Firdouse, A; Manuprasad, BK; Rai, NP; Shashikanth, S; Venu, TD | 1 |
| Abu-Hashem, AA; Badria, FA; Gouda, MA | 1 |
| Baraka, MM; El-Sabbagh, OI; Ibrahim, SM; Kothayer, H | 1 |
| Borg, J; Crook, J; Ma, C; Patil, N; Pond, G; Wallace, K; Zhou, D | 1 |
| Cury, PR; De Menezes, SA | 1 |
| Schiffer, CA; Zonder, JA | 1 |
| Cheon, HG; Cho, YS; Kang, NS; Kim, CH; Surh, JH; Yoo, SE | 1 |
| Gautam, R; Jachak, SM; Khan, T; Madhan, H; Selvam, C; Srivastava, A | 1 |
| Loh, JS; Ong, CW | 1 |
| Bekhit, AA; El-Din A Bekhit, A; Fahmy, HT; Rostom, SA | 1 |
| Aslan, SS; Barla, A; Gönüllü, Ü; Kiliç, P; Üner, M; Yener, G; Yildirim, S | 1 |
| Abbruzzi, A; Bromberg, J; Chang, J; D'Andrea, G; Dang, C; Dickler, M; Fornier, MN; Gilewski, T; Hudis, CA; Modi, S; Morris, PG; Norton, L; Seidman, AD; Sklarin, N | 1 |
| Date, AA; Khachane, P; Nagarsenker, MS | 1 |
| Isiordia-Espinoza, MA; Reyes-García, JG; Sánchez-Prieto, M; Tobías-Azúa, F | 1 |
| Chi, CS; Deng, JS; Huang, GJ; Huang, SS; Lin, TH; Shie, PH | 1 |
| Baiuomy, AR; Elmegeed, GA; Eskander, EF; Mohareb, RM; William, MG | 1 |
| Chang, PT; Chen, CS; Chen, GS; Chern, JW; Tan, CM | 1 |
| Doubova, SV; Flores-Hernández, S; Mino-León, D; Reyes-Morales, H | 1 |
| Cheon, HG; Cho, YS; Suh, J; Yum, EK | 1 |
| Bobade, VD; Mhaske, PC; Nandave, M; Narkhade, S; Shelke, SH; Walhekar, NM | 1 |
| Apostolidis, I; Ćirić, A; Gavalas, A; Geronikaki, A; Glamočlija, J; Hadjipavlou-Litina, D; Liaras, K; Soković, M | 1 |
| Atilla, P; Balkan, A; Cakar, AN; Caliş, U; Gören, Z; Urgun, H; Uzbay, T | 1 |
| Janney, LM; Niemeyer, NV | 1 |
| Beck-Sickinger, A; Demuth, H; Dimitrijević, M; Kovacević-Jovanović, V; Stanojević, S; von Hörsten, S; Vujić, V | 1 |
| Herrmann, A; Hesselbarth, N; Hippius, M; Hoffmann, A; Kuschel, U | 1 |
| Hiratani, K; Iwata, M; Kobayashi, M | 1 |
| Aleksunes, LM; Reagan, LA; Vergara, CM; Wang, F | 1 |
| Baraka, AM; Bekhit, AA; Fahmy, HT; Rostom, SA | 1 |
| Aranyi, P; Batori, S; Finance, O; Kapui, Z; Mikus, E; Szabo, T; Szeredi, J; Urban-Szabo, K; Varga, M | 1 |
| Agarwal, SP; Baboota, S | 1 |
| Holla, BS; Kumari, NS; Malini, KV; Rao, BS; Sarojini, BK | 1 |
| Francis, GS; Hoogwerf, BJ; Tang, WH; Young, JB | 1 |
| Inoue, N; Matsui, M; Tachibana, M; Ukai, Y; Yano, J; Yoshida, E | 1 |
| Baba, T; Inagaki, M; Iwatani, K; Jyoyama, H; Kobayashi, M; Matsumoto, S; Ohkawa, T; Ono, T; Touchi, A; Tsuri, T; Yamada, K | 1 |
| Buse, JB | 1 |
| Dündar, Y; Küpeli, E; Noyanalpan, N; Okçelik, B; Onkol, T; Sahin, MF; Unlü, S; Yeşilada, E | 1 |
| Bahekar, RH; Bhusari, KP; Chopade, RS; Khedekar, PB; Rao, AR; Umathe, SN | 1 |
| Nasr, MN; Said, SA | 1 |
| Ertan, M; Gökhan, N; Küpeli, E; Tozkoparan, B; Yeşilada, E | 1 |
| Geronikaki, A; Hadjipavlou-Litina, D; Incerti, M; Vicini, P | 1 |
| Decker, MW; Gauvin, DM; Honore, P; Lynch, JJ; Mikusa, JP; Wade, CL; Wilson, SG; Wismer, CT; Zhu, CZ | 1 |
| Bajaj, K; Kumar, A; Lahoti, AM; Lozach, O; Meijer, L; Singh, N; Sondhi, SM | 1 |
| Bolos, CA; Chaviara, AT; Hadjipavlou-Litina, D; Pontiki, E | 1 |
| Chou, YH; Ku, HL; Su, TP | 1 |
| Machoń, Z; Miedzybrodzki, R; Regiec, A; Szymaniec, S | 1 |
| Benetello, V; Calvo, AM; Colombini, BL; Dionísio, TJ; Faria, FA; Freire, TM; Giglio, FP; Lauris, JR; Modena, KC; Sakai, VT; Sakamoto, FC; Santos, CF; Trindade, AS | 1 |
| Countouriotis, A; Golenkov, A; Hamerschlak, N; Hellmann, A; Holowiecki, J; Hughes, T; Jootar, S; Kantarjian, H; Khoroshko, N; Masszi, T; Pasquini, R; Radich, J; Robak, T; Rousselot, P; Shah, N; Skotnicki, A; Zaritsky, A | 1 |
| Franklin, PX; Nivsarkar, M; Padh, H; Pillai, AD; Rathod, PD; Sudarsanam, V; Vasu, KK; Yerande, S | 1 |
| Abdel Ghany, YS; Ashour, HM; Baraka, A; Bekhit, AA; Bekhit, Ael-D | 1 |
| Chung, SH; Han, EJ; Ren, J | 1 |
| Bhati, SK; Kumar, A; Singh, N | 1 |
| Cho, IJ; Kim, SC; Kim, SG; Kim, YW; Lee, JR; Park, SJ; Yang, CH; Zhao, RJ | 1 |
| Bajel, A; Bassili, S; Seymour, JF | 1 |
| Ando, K; Nagatomi, H | 1 |
| Geronikaki, A; Kourounakis, PN; Mgonzo, R | 1 |
| Albert, DH; Carter, GW; Conway, RG; Davidsen, SK; Holms, JH; Luo, G; Magoc, TJ; Rhein, DA; Summers, JB; Tapang, P | 1 |
| Amico-Roxas, M; Caruso, A; Cutuli, V; Di Pietro, E; Modica, M; Russo, F; Santagati, A; Santagati, M | 1 |
| Devissaguet, M; Ferreira, SH; Lesieur, D; Lorenzetti, BB; Tsouderos, Y | 1 |
| Lagorce, JF; Moulard, T; Raby, C; Thomas, JC | 1 |
| Chantegrel, J; de Lima, JG; Luu-Duc, C; Narcisse, G; Perrissin, M; Rousseau, A | 1 |
| Bures, MG; Carrera, GM; Davidsen, SK; Guinn, DE; Heyman, HR; May, PD; Phillips, JG; Pireh, D; Sheppard, GS; Steinman, DH | 1 |
| Naik, PR; Pandeya, SN | 1 |
| Geronikaki, AA; Hadjipavlou-Litina, DJ | 3 |
| Fenech, G; Forestieri, AM; Giordano, A; Monforte, MT; Previtera, T; Vigorita, MG; Zappala, C | 1 |
| Brown, GS; Counts, DF; Kelsey, LS; Talmadge, JE | 1 |
| Morimoto, Y; Oda, M; Yamamoto, N; Yamashita, A; Yokota, K | 1 |
| Ambrogi, V; Arenare, L; De Caprariis, P; Falcone, G; Filippelli, W; Grandolini, G; Palagiano, F; Perioli, L; Rossi, F | 1 |
| Marini, M; Passarotti, CM; Valenti, M | 1 |
| Afify, M; Goldmann, C; Khorram-Sefat, R; Klosterhalfen, B; Küpper, W; Lennartz, A; Mottaghy, K; Radke, A | 1 |
| Horishny, V; Lesyk, R; Nektegayev, I; Solyanyk, V; Vladzimirska, O; Vovk, O; Zimenkovsky, B | 1 |
| Demirdamar, R; Ertan, M; Kelicen, P; Krebs, B; Läge, M; Tozkoparan, B | 1 |
| Chakrabarti, R; Kumar, TD; Madhusudhan, G; Prabhakar, C; Rajagopalan, R; Rao, CS; Reddy, CM; Reddy, GO; Sahadev, K; Sarma, MR | 1 |
| Gorson, DM | 1 |
| Bornemeier, DA; Chan, K; Connor, DT; Doubleday, R; Dyer, RD; Gilbertsen, RB; Guglietta, A; Roth, BD; Schrier, DJ; Sercel, AD; Song, Y; Sorenson, RJ; Unangst, PC | 1 |
| Naik, PR; Pandeya, SN; Singh, PN; Singh, S | 1 |
| Demirdamar, R; Ertan, M; Ertan, R; Kelicen, P; Kilcigil, GA; Tozkoparan, B | 1 |
| Chang, MS; Cheon, SA; Cho, SI; Chung, YK; Kim, KB; Lee, EB; Sohn, SK | 1 |
| Geronikaki, AA; Hadjipavlou-Litina, DJ; Tzaki, M | 1 |
| Ondo, W; Tan, EK | 1 |
| Arimura, A; Hori, Y; Inagaki, M; Jyoyama, H; Kakudo, S; Kato, M; Kawai, S; Kobayashi, M; Koizumi, K; Matsumoto, S; Ohno, K; Ono, T; Suzuki, R; Tsuri, T; Yamada, K; Yasui, K | 1 |
| King, AB | 1 |
| Brukstus, A; Bucinskaite, V; Dauksas, V; Gaidelis, P; Labanauskas, L; Udrenaite, E | 1 |
| Caruso, A; Cutuli, V; Mangano, N; Modica, M; Santagati, A; Santagati, M | 1 |
| Hanna, PA; Jankovic, J; Ondo, WG; Ratkos, L | 1 |
| Aktay, G; Ertan, M; Tozkoparan, B; Yesilada, E | 1 |
| Bondavalli, F; Bruno, O; Falcone, G; Filippelli, W; Giordano, L; Ranise, A; Schenone, S; Vitelli, MR | 1 |
| Aktay, G; Berk, B; Ertan, M; Yesilada, E | 1 |
| Belcher, G; Hanefeld, M | 1 |
| Iwata, M; Kobayashi, M | 1 |
| Cerdá-Nicolás, M; Giner, RM; Giner-Larza, EM; Máñez, S; Prieto, JM; Recio, MC; Ríos, JL | 1 |
| Goto, T; Ochi, T | 1 |
| Akarca, C; Barton, DM; Baskar, V; Buch, HN; Kamalakannan, D; Singh, BM | 1 |
| Iso, T; Iwao, J; Nakajima, N; Nishimura, K; Suda, H; Yamauchi, H | 1 |
| Cerutti, S; Forlani, A; Sperandeo, F | 1 |
| Kopp, H | 1 |
| Barthwal, JP; Bhargava, KP; Pandey, BR; Parmar, SS; Raman, K | 1 |
| Abri, AR | 1 |
| Barthwal, JP; Bhargava, KP; Pandey, BR; Raman, K | 1 |
| Cerutti, S; D'Atri, G; Forlani, A; Galimberti, E | 1 |
| Fatimi, J; Lagorce, JF; Lakhdar, M; Nefaoui, S; Raby, C | 1 |
| Arrigo-Reina, R; Barbera, F; Castorina, C; Catti, T; Chiechio, S; Mazzone, G; Mazzone, S; Panico, A; Pignatello, R; Russo, A | 1 |
| Barocelli, E; Bordi, F; Chiavarini, M; Impicciatore, M; Mor, M; Morini, G; Plazzi, PV; Silva, C | 1 |
| Bernat, A; Herbert, JM; Laplace, MC; Maffrand, JP; Salel, V | 1 |
| Becker, R; Cullen, E; Freter, K; LeClerq, T; Possanza, G; Wong, HC | 1 |
| Kondo, N; Motoyoshi, F; Ono, H; Orii, T | 1 |
| Attaguile, G; Bousquet, E; Caruso, A; Guccione, S; Leone, MG; Romeo, G; Roxas, MA; Russo, F | 1 |
| Engelhardt, G; Trummlitz, G | 1 |
| Bender, PE; Griswold, DE; Hanna, N; Hillegass, L; Hoffstein, S; Marshall, PJ; Webb, EF | 1 |
| Berkowitz, BA; DiMartino, MJ; Griswold, DE; Hanna, N; Poste, G | 1 |
| Barthwal, JP; Bhalla, TN; Kumar, P; Pande, K; Tandon, M | 1 |
| Bertez, C; Bonne, C; Conduzorgues, JP; Legrand, A; Sincholle, D | 1 |
| Jaques, R; Majer, H; Riesterer, L | 1 |
| Agosti, A; Gaetani, E; Mantovani, P; Vitali, T | 1 |
| Brown, K; Cater, DP; Cavalla, JF; Green, D; Newberry, RA; Wilson, AB | 1 |
| Colombo, M; Márquez, M; Moragues, J; Roberts, DJ; Thiele, K | 1 |
| Márquez, M; Roberts, DJ | 1 |
| Lombardino, JG; Wiseman, EH | 1 |
| Mörsdorf, K; Wolf, G | 1 |
| Iwasaki, M; Miyamatsu, H; Shimizu, M; Suzuki, T; Ueno, S; Wada, J | 1 |
| Hosono, J; Miyamatsu, H; Shimizu, M; Tomari, M; Ueno, S | 1 |
| Braud, J; Héraud, G; Léonard, C; Roux, E | 1 |
| Go, K; Hayashi, M; Hiramatsu, Y; Tsurumi, K; Yamaguchi, A | 1 |
| Ciaceri, G; Gialdi, L; Pennisi, G | 1 |
| Allen, GR; McEvoy, FJ | 1 |
| Kado, Y; Kumada, S; Takashima, T | 1 |
| Fujimura, H; Hayashi, M; Hiramatsu, Y; Nozaki, M; Tsurumi, K | 1 |
| Brown, K; Cavalla, JF; Green, D; Wilson, AB | 1 |
| Hanna, C; Thomason, HJ | 1 |
7 review(s) available for thiazoles and Edema
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate.
Topics: Algorithms; Antineoplastic Agents; Benzamides; Blast Crisis; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Combined Modality Therapy; Dasatinib; Drug Eruptions; Drug Interactions; Edema; Fusion Proteins, bcr-abl; Gastrointestinal Diseases; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Salvage Therapy; Thiazoles | 2006 |
Thiazolidinedione-induced edema.
Topics: Aged; Edema; Humans; Male; Middle Aged; Thiazoles; Thiazolidinediones | 2002 |
[Pioglitazone].
Topics: Animals; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2002 |
Management of rosiglitazone-induced edema: two case reports and a review of the literature.
Topics: Body Weight; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diuresis; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
Safety profile of pioglitazone.
Topics: Cardiovascular System; Edema; Humans; Hypoglycemic Agents; Pioglitazone; Randomized Controlled Trials as Topic; Thiazoles; Thiazolidinediones; Weight Gain | 2001 |
[Evaluation of thiazolidinedione derivative drugs for safety].
Topics: Animals; Chemical and Drug Induced Liver Injury; Chromans; Clinical Trials as Topic; Edema; Heart Failure; Humans; Hypoglycemic Agents; Pioglitazone; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
12 trial(s) available for thiazoles and Edema
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Single dose of diclofenac or meloxicam for control of pain, facial swelling, and trismus in oral surgery.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Edema; Female; Humans; Male; Meloxicam; Molar, Third; Pain, Postoperative; Thiazines; Thiazoles; Tooth Extraction; Trismus; Young Adult | 2016 |
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Asthmatic Agents; Asthma; Benzamides; Edema; Exanthema; Female; France; Humans; Hydroxycorticosteroids; Male; Medication Adherence; Middle Aged; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyridines; Receptors, Platelet-Derived Growth Factor; Thiazoles; Treatment Outcome | 2009 |
A phase III randomized trial of the timing of meloxicam with iodine-125 prostate brachytherapy.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Brachytherapy; Cyclooxygenase 2 Inhibitors; Drug Administration Schedule; Edema; Humans; Iodine Radioisotopes; Male; Meloxicam; Middle Aged; Ontario; Prostatic Diseases; Thiazines; Thiazoles; Urinary Retention | 2010 |
Efficacy of nimesulide versus meloxicam in the control of pain, swelling and trismus following extraction of impacted lower third molar.
Topics: Cross-Over Studies; Cyclooxygenase Inhibitors; Edema; Female; Humans; Male; Meloxicam; Molar, Third; Pain Measurement; Pain, Postoperative; Sulfonamides; Thiazines; Thiazoles; Tooth Extraction; Tooth, Impacted; Trismus; Young Adult | 2010 |
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Breast Neoplasms, Male; Dasatinib; Edema; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pleural Effusion, Malignant; Pyrimidines; Thiazoles; Treatment Outcome | 2011 |
Pre-emptive analgesic effectiveness of meloxicam versus tramadol after mandibular third molar surgery: a pilot study.
Topics: Adolescent; Adult; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Edema; Female; Humans; Injections, Intramuscular; Ketorolac; Male; Mandible; Meloxicam; Molar, Third; Pain Measurement; Pain, Postoperative; Pilot Projects; Postoperative Complications; Premedication; Thiazines; Thiazoles; Time Factors; Tooth Extraction; Tooth, Impacted; Tramadol; Trismus; Young Adult | 2012 |
Analgesic and anti-inflammatory dose-response relationship of 7.5 and 15 mg meloxicam after lower third molar removal: a double-blind, randomized, crossover study.
Topics: Administration, Oral; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Edema; Female; Humans; Male; Meloxicam; Molar, Third; Osteotomy; Pain, Postoperative; Range of Motion, Articular; Statistics, Nonparametric; Thiazines; Thiazoles; Tooth Extraction; Tooth, Impacted; Trismus | 2007 |
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Cytogenetic Analysis; Dasatinib; Disease-Free Survival; Drug Resistance; Edema; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pancytopenia; Piperazines; Pleural Effusion; Pyrimidines; Salvage Therapy; Thiazoles; Treatment Outcome | 2007 |
A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones.
Topics: Body Weight; Cholesterol, LDL; Chromans; Diabetes Mellitus, Type 2; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 2000 |
Switching from pergolide to pramipexole in patients with Parkinson's disease.
Topics: Accidental Falls; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Edema; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Pramipexole; Prospective Studies; Receptors, Dopamine; Sweating; Thiazoles; Treatment Outcome | 2001 |
[Etozoline in the ambulatory edema therapy of decompensated cardiac patients].
Topics: Diuretics; Edema; Female; Heart Failure; Humans; Male; Mefruside; Piperidines; Thiazoles | 1979 |
154 other study(ies) available for thiazoles and Edema
| Article | Year |
|---|---|
New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition.
Topics: Analgesics; Anti-Inflammatory Agents; Cardiotoxicity; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Humans; Molecular Docking Simulation; Pyrimidines; Structure-Activity Relationship; Thiazoles | 2022 |
Periorbital edema associated with alpelisib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Class I Phosphatidylinositol 3-Kinases; Edema; Exanthema; Humans; Phosphatidylinositol 3-Kinases; Receptor, ErbB-2; Thiazoles | 2022 |
Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
Topics: Administration, Oral; Aminosalicylic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 15-Lipoxygenase; Carrageenan; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Edema; Humans; Indomethacin; Lipoxygenase Inhibitors; Male; Molecular Docking Simulation; Molecular Structure; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 2020 |
Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 15-Lipoxygenase; Benzimidazoles; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Edema; Lipoxygenase Inhibitors; Male; Molecular Structure; Rats; Structure-Activity Relationship; Thiazoles | 2020 |
Synthesis of novel 2, 3, 5-tri-substituted thiazoles with anti-inflammatory and antibacterial effect causing clinical pathogens.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Edema; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Microbial Sensitivity Tests; Rats; Structure-Activity Relationship; Thiazoles | 2020 |
Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Green Chemistry Technology; Humans; Lipoxygenase Inhibitors; Male; Mice; Rats, Wistar; RAW 264.7 Cells; Thiazoles | 2020 |
Synthesis and evaluations of selective COX-2 inhibitory effects: Benzo[d]thiazol analogs.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Design; Edema; Mice; Structure-Activity Relationship; Thiazoles | 2020 |
Synthesis, anti-inflammatory and analgesic evaluation of thiazole/oxazole substituted benzothiazole derivatives.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Benzothiazoles; Edema; Mice; Molecular Conformation; Oxazoles; Pain; Rats; Structure-Activity Relationship; Thiazoles | 2021 |
Design, synthesis, biological evaluation, and computational studies of novel thiazolo-pyrazole hybrids as promising selective COX-2 inhibitors: Implementation of apoptotic genes expression for ulcerogenic liability assessment.
Topics: Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Apoptosis; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Edema; Formaldehyde; Male; Models, Molecular; Molecular Structure; Pyrazoles; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 2021 |
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cytokines; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Edema; ErbB Receptors; Heart; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; Rats; Structure-Activity Relationship; Thiazoles | 2021 |
Disfiguring angioedema-like airborne dermatitis from methylisothiazolinone in paints: About time to regulate?
Topics: Adrenal Cortex Hormones; Angioedema; Cough; Dermatitis, Allergic Contact; Diagnosis, Differential; Edema; Facial Dermatoses; Housing; Humans; Male; Middle Aged; Paint; Patch Tests; Thiazoles | 2021 |
A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
Topics: Administration, Oral; Amides; Animals; Anti-Inflammatory Agents; Carrageenan; Drug Combinations; Edema; Ethanolamines; Hyperalgesia; Inflammation; Male; Meloxicam; Osteoarthritis; Pain; Palmitic Acids; Quercetin; Rats, Sprague-Dawley; Thiazines; Thiazoles | 2017 |
7-Chloro-4-phenylsulfonyl quinoline, a new antinociceptive and anti-inflammatory molecule: Structural improvement of a quinoline derivate with pharmacological activity.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Croton Oil; Edema; Hot Temperature; Humans; Male; Meloxicam; Mice; Nociception; Pain; Quinolines; Stomach Ulcer; Thiazines; Thiazoles | 2017 |
Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities.
Topics: A549 Cells; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Binding Sites; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; ErbB Receptors; HT29 Cells; Humans; Inhibitory Concentration 50; MCF-7 Cells; Molecular Docking Simulation; Protein Structure, Tertiary; Proto-Oncogene Proteins B-raf; Rats; Thiazoles; Tubulin | 2017 |
Novel 2-(nitrooxy)ethyl 2-(4-(substituted phenyl)-2-((substituted phenyl)amino)thiazol-5-yl)acetate as Anti-inflammatory, Analgesic and Nitric Oxide Releasing Agents: Synthesis and Molecular Docking Studies.
Topics: Acetates; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Edema; Female; Humans; Male; Mice; Molecular Docking Simulation; Nitric Oxide; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazoles | 2017 |
Discovery of Thiazole Based Bis Heterocyclic System for Anti- Inflammatory Potential.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Capillary Permeability; Carrageenan; Cyclooxygenase 2; Drug Design; Drug Discovery; Edema; Heterocyclic Compounds; Humans; Mice; Protein Binding; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazoles | 2017 |
Rutin and meloxicam attenuate paw inflammation in mice: Affecting sorbitol dehydrogenase activity.
Topics: Acute Pain; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Behavior, Animal; Cellulitis; Connective Tissue; Disease Models, Animal; Drug Therapy, Combination; Edema; L-Iditol 2-Dehydrogenase; Liver; Male; Meloxicam; Mice; Organ Size; Oxidative Stress; Random Allocation; Rutin; Superoxide Dismutase; Thiazines; Thiazoles | 2018 |
Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Edema; Formaldehyde; Indomethacin; Male; Molecular Docking Simulation; Molecular Structure; Rats; Rats, Wistar; Sheep; Structure-Activity Relationship; Thiazoles; Ulcer | 2019 |
Pharmacological investigation of quinoxaline-bisthiazoles as multitarget-directed ligands for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartic Acid Endopeptidases; Binding Sites; Brain; Catalytic Domain; Drug Design; Edema; Humans; Ligands; Maze Learning; Molecular Docking Simulation; Neuroprotective Agents; Protease Inhibitors; Quinoxalines; Rats; Structure-Activity Relationship; Thiazoles | 2019 |
Synthesis and pharmacological evaluation of some novel 2-(5-hydroxy-5-trifluoromethyl-4,5-dihydropyrazol-1-yl)-4-(coumarin-3-yl)thiazoles.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Coumarins; Dose-Response Relationship, Drug; Edema; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Microbial Sensitivity Tests; Molecular Structure; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazoles | 2013 |
Dual evaluation of some novel 2-amino-substituted coumarinylthiazoles as anti-inflammatory-antimicrobial agents and their docking studies with COX-1/COX-2 active sites.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Candida albicans; Carrageenan; Catalytic Domain; Coumarins; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Molecular Docking Simulation; Molecular Structure; Rats; Rats, Wistar; Saccharomyces cerevisiae; Structure-Activity Relationship; Thiazoles | 2014 |
Synthesis and biological evaluation of some novel thiazole compounds as potential anti-inflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacillus cereus; Carrageenan; Dose-Response Relationship, Drug; Edema; Microbial Sensitivity Tests; Molecular Structure; Proteus mirabilis; Rats; Rats, Wistar; Serratia; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2013 |
A case of eyelid contact dermatitis by "ipoallergic" eye-cleansing.
Topics: Adult; Dermatitis, Allergic Contact; Detergents; Eczema; Edema; Erythema; Eyelid Diseases; Female; Humans; Thiazoles | 2013 |
Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Drug Carriers; Edema; Gels; Hydrogen-Ion Concentration; Meloxicam; Nanostructures; Particle Size; Rats; Rheology; Skin Absorption; Surface Properties; Thiazines; Thiazoles | 2013 |
Meloxicam-loaded nanocapsules have antinociceptive and antiedematogenic effects in acute models of nociception.
Topics: Acute Pain; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Croton Oil; Ear; Edema; Extremities; Formaldehyde; Glutamic Acid; Male; Meloxicam; Mice; Nanocapsules; Nociception; Pain Measurement; Thiazines; Thiazoles | 2014 |
Synthesis and biological evaluation of pyrazolylthiazole carboxylic acids as potent anti-inflammatory-antimicrobial agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Carboxylic Acids; Edema; Fungi; Gram-Positive Bacteria; Indomethacin; Microbial Sensitivity Tests; Pyrazoles; Rats; Thiazoles | 2015 |
Synthesis, anti-inflammatory and anti-ulcer evaluations of thiazole, thiophene, pyridine and pyran derivatives derived from androstenedione.
Topics: Androstenedione; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Drug Evaluation, Preclinical; Edema; Pyrans; Pyridines; Rats; Thiazoles; Thiophenes | 2015 |
Novel thiazolo[3,2-b]-1,2,4-triazoles derived from naproxen with analgesic/anti-inflammatory properties: Synthesis, biological evaluation and molecular modeling studies.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Disease Models, Animal; Drug Design; Edema; Humans; Inflammation; Mice; Molecular Docking Simulation; Molecular Dynamics Simulation; Naproxen; Nociception; Pain; Pain Measurement; Structure-Activity Relationship; Thiazoles; Thiones; Triazoles | 2015 |
Design, synthesis, and anti-inflammatory evaluation of novel diphenylthiazole-thiazolidinone hybrids.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Design; Edema; Hyperalgesia; Mice; Molecular Docking Simulation; Protein Binding; Thiazoles | 2015 |
Evaluation of the local inflammatory events induced by BpirMP, a metalloproteinase from Bothrops pirajai venom.
Topics: Animals; Bothrops; Cell Degranulation; Cromolyn Sodium; Crotalid Venoms; Cyclooxygenase Inhibitors; Edema; Female; Histamine H1 Antagonists; Hyperalgesia; Inflammation; Interleukin-10; Interleukin-6; Leukocytes; Male; Mast Cells; Meloxicam; Metalloproteases; Mice; Mice, Inbred BALB C; Nitric Oxide; Nociception; Pyrilamine; Rats; Rats, Wistar; Salicylates; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Viper Venoms | 2015 |
Anti-inflammatory, Analgesic and Anti-ulcerogenic Activities of Novel bis-thiadiazoles, bis-thiazoles and bis-formazanes.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Edema; Formazans; Male; Mice; Molecular Structure; Nociceptive Pain; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 2017 |
Hunger oedema and thiamine deficiency.
Topics: Deficiency Diseases; Edema; Humans; Hunger; Salts; Thiamine; Thiamine Deficiency; Thiazoles | 1947 |
Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice.
Topics: Analysis of Variance; Animals; Body Weight; Brain; Centella; Dose-Response Relationship, Drug; Eating; Edema; Glutathione; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mitochondria; Nitro Compounds; Oxidative Stress; Plant Extracts; Protein Carbonylation; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Triterpenes | 2008 |
Evaluation of anti-inflammatory and antioxidant activities of copper (II) Schiff mono-base and copper(II) Schiff base coordination compounds of dien with heterocyclic aldehydes and 2-amino-5-methyl-thiazole.
Topics: Aldehydes; Animals; Anti-Inflammatory Agents; Antioxidants; Carrageenan; Copper; Edema; Heterocyclic Compounds; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Rats; Schiff Bases; Thiazoles | 2008 |
Synthesis, anticancer, and anti-inflammatory activity evaluation of methanesulfonamide and amidine derivatives of 3,4-diaryl-2-imino-4-thiazolines.
Topics: Amidines; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carrageenan; Cell Line, Tumor; Disease Models, Animal; Drug Screening Assays, Antitumor; Edema; Female; Humans; Male; Pregnancy; Rats; Sulfonamides; Thiazoles | 2009 |
Synthesis of 4-benzyl-1,3-thiazole derivatives as potential anti-inflammatory agents: an analogue-based drug design approach.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Benzyl Compounds; Carrageenan; Dose-Response Relationship, Drug; Drug Design; Edema; Female; Hindlimb; Male; Oxazoles; Plethysmography; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles; Thiazolidines | 2009 |
A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Chemistry, Pharmaceutical; Diffusion; Disease Models, Animal; Dosage Forms; Drug Compounding; Drug Stability; Edema; Excipients; Freund's Adjuvant; Meloxicam; Mice; Mice, Hairless; Mycobacterium; Osteoarthritis; Permeability; Piroxicam; Povidone; Rats; Rats, Sprague-Dawley; Skin; Skin Absorption; Solubility; Technology, Pharmaceutical; Thiazines; Thiazoles; Tissue Adhesives | 2010 |
Synthesis and biological activities of new substituted thiazoline-quinoline derivatives.
Topics: Acetophenones; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Edema; Fluoroquinolones; Fungi; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Indomethacin; Ketoconazole; Lethal Dose 50; Male; Mice; Quinolines; Rats; Stomach Ulcer; Thiazoles; Toxicity Tests, Acute | 2009 |
Synthesis of some novel 2-[2-(aroyl-aroxy)-methyl]-4-phenyl-1,3-thiazoles as potent anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Benzophenones; Edema; Rats; Thiazoles; Toxicity Tests | 2010 |
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Drug Evaluation, Preclinical; Edema; Female; Male; Mice; Molecular Structure; Pain; Pain Measurement; Pyrimidines; Quinoxalines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles | 2010 |
Synthesis of new 2,3-dihydroquinazolin-4(1H)-one derivatives for analgesic and anti-inflammatory evaluation.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Chalcones; Drug Evaluation, Preclinical; Edema; Male; Mice; Molecular Structure; Pain; Pain Measurement; Pyrazoles; Quinazolinones; Rats; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 2010 |
Identification of 4-[4-(4-fluoro-phenyl)-thiazol-2-ylamino]-2,6-dimethyl-phenol (KR-33749) as an inhibitor of 5-lipoxygenase with potent antiinflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Line, Tumor; Dermatitis, Atopic; Dinitrochlorobenzene; Dose-Response Relationship, Drug; Edema; Isoenzymes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Osmolar Concentration; Rats; Recombinant Proteins; Skin; Skin Diseases; Thiazoles; Time Factors; Xylenes | 2010 |
Anti-inflammatory, cyclooxygenase inhibitory and antioxidant activities of standardized extracts of Tridax procumbens L.
Topics: Animals; Antioxidants; Asteraceae; Benzothiazoles; Biphenyl Compounds; Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Edema; Female; Flavonoids; Phenols; Phytotherapy; Picrates; Plant Components, Aerial; Plant Extracts; Polyphenols; Rats; Rats, Sprague-Dawley; Sulfonic Acids; Thiazoles | 2011 |
Efficacy of nimesulide versus meloxicam in the control of pain, swelling and trismus following extraction of impacted lower third molar [Int. J. Oral Maxillofac. Surg. 39 (2010) 580-584].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Edema; Humans; Meloxicam; Molar, Third; Pain, Postoperative; Sulfonamides; Thiazines; Thiazoles; Tooth Extraction; Tooth, Impacted; Trismus | 2011 |
Synthesis and biological evaluation of some thiazolylpyrazole derivatives as dual anti-inflammatory antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Candida albicans; Carrageenan; Catalytic Domain; Cotton Fiber; Cyclooxygenase 1; Cyclooxygenase 2; Edema; Escherichia coli; Granuloma; Humans; Male; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Pyrazoles; Rats; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2010 |
Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Drug Delivery Systems; Edema; Hypromellose Derivatives; Meloxicam; Methylcellulose; Piroxicam; Rats; Rats, Wistar; Skin; Spectroscopy, Fourier Transform Infrared; Tensile Strength; Thiazines; Thiazoles | 2010 |
Positively charged polymeric nanoparticles: application in improving therapeutic efficacy of meloxicam after oral administration.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caproates; Carrageenan; Edema; Foot; Freeze Drying; Lactones; Male; Meloxicam; Nanoparticles; Particle Size; Polymers; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Surface-Active Agents; Suspensions; Thiazines; Thiazoles | 2011 |
Antioxidant, analgesic, and anti-inflammatory activities of the ethanolic extracts of Taxillus liquidambaricola.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Benzothiazoles; Biphenyl Compounds; Carrageenan; Catalase; Cell Line; Chromatography, High Pressure Liquid; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Edema; Endotoxins; Ethanol; Formaldehyde; Glutathione Peroxidase; Loranthaceae; Macrophages; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Nitric Oxide; Nitric Oxide Synthase Type II; Pain; Picrates; Plants, Medicinal; Solvents; Sulfonic Acids; Superoxide Dismutase; Thiazoles; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Evaluation of anti-inflammatory, anti-nociceptive, and anti-ulcerogenic activities of novel synthesized thiazolyl and pyrrolyl steroids.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Carrageenan; Disease Models, Animal; Edema; Inflammation; Pain; Pyrroles; Rats; Rats, Sprague-Dawley; Steroids; Stomach Ulcer; Thiazoles; Ulcer | 2011 |
Design, synthesis and biological evaluation of benzo[1.3.2]dithiazolium ylide 1,1-dioxide derivatives as potential dual cyclooxygenase-2/5-lipoxygenase inhibitors.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Humans; Inhibitory Concentration 50; Lipoxygenase Inhibitors; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Molecular Structure; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazoles | 2011 |
Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico.
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Follow-Up Studies; Glyburide; Humans; Hypoglycemic Agents; Male; Medication Adherence; Metformin; Mexico; Middle Aged; Pharmacovigilance; Prospective Studies; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2012 |
Synthesis and biological evaluation of N-aryl-4-aryl-1,3-thiazole-2-amine derivatives as direct 5-lipoxygenase inhibitors.
Topics: Administration, Oral; Amines; Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Edema; Lipoxygenase Inhibitors; Mice; Rats; Structure-Activity Relationship; Thiazoles | 2012 |
Synthesis and pharmacological evaluation of a novel series of 3-aryl-2-(2-substituted-4-methylthiazole-5-yl)thiazolidin-4-one as possible anti-inflammatory and antimicrobial agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Bacteria; Bacterial Infections; Carrageenan; Edema; Fungi; Humans; Indomethacin; Microbial Sensitivity Tests; Mycoses; Rats; Thiazoles; Thiazolidines | 2012 |
Synthesis and biological evaluation of some 5-arylidene-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-ones as dual anti-inflammatory/antimicrobial agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Edema; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Thiazoles | 2013 |
Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemical Phenomena; Disease Models, Animal; Edema; Female; Gels; Hemolysis; Humans; Male; Meloxicam; Nanotechnology; Particle Size; Rats; Rheology; Skin; Skin Absorption; Surface Properties; Thiazines; Thiazoles | 2013 |
Evaluation of the analgesic and anti-inflammatory activities of some thiazolo[4,5-d]pyrimidines.
Topics: Acetic Acid; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Edema; Gastric Mucosa; Mice; Pain; Pyrimidines; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 2002 |
Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26).
Topics: Animals; Arginine; Cells, Cultured; Concanavalin A; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Edema; Hydrogen Peroxide; Inflammation; Isoleucine; Macrophages; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Thiazoles | 2002 |
[Severe electrolyte imbalance and edema in therapy with rosiglitazone].
Topics: Chemical and Drug Induced Liver Injury; Contraindications; Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Liver Diseases, Alcoholic; Liver Function Tests; Male; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Water-Electrolyte Imbalance | 2002 |
Design and synthesis of some substituted 1H-pyrazolyl-thiazolo[4,5-d]pyrimidines as anti-inflammatory-antimicrobial Agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Cyclooxygenase 1; Cyclooxygenase 2; Drug Design; Edema; Granuloma; Humans; Isoenzymes; Membrane Proteins; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrimidines; Rats; Structure-Activity Relationship; Thiazoles; Toxicity Tests, Acute; Ulcer | 2003 |
Biochemical and pharmacological characterization of 2-(9-(2-piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-methylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a novel, orally active elastase inhibitor.
Topics: Algorithms; Animals; Bronchoalveolar Lavage Fluid; Carrageenan; Cyclic S-Oxides; Dose-Response Relationship, Drug; Edema; Elastin; Enzyme Inhibitors; Hemorrhage; Humans; Hydrolysis; Kinetics; Leukocyte Elastase; Male; Mice; Oligopeptides; Rabbits; Rats; Thiazoles | 2003 |
Meloxicam complexation with beta-cyclodextrin: influence on the anti-inflammatory and ulcerogenic activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Cyclodextrins; Edema; Intestinal Mucosa; Male; Meloxicam; Rats; Rats, Wistar; Stomach Ulcer; Thiazines; Thiazoles | 2003 |
Synthesis of some new 2,4-disubstituted thiazoles as possible antibacterial and anti-inflammatory agents.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Carrageenan; Dimethyl Sulfoxide; Edema; Granulation Tissue; Ibuprofen; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Rats; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared; Thiazoles | 2003 |
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.
Topics: Adult; Aged; Ascites; Diabetes Complications; Diabetes Mellitus; Dilatation, Pathologic; Edema; Female; Heart Failure; Humans; Hypoglycemic Agents; Incidence; Jugular Veins; Male; Medical Records; Middle Aged; Predictive Value of Tests; Pulmonary Edema; Retrospective Studies; Severity of Illness Index; Systole; Thiazoles; Thiazolidinediones | 2003 |
Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cyclooxygenase Inhibitors; Diclofenac; Edema; Etodolac; Gastric Mucosa; Indomethacin; Male; Meloxicam; Mice; Peptic Ulcer; Rats; Species Specificity; Thiazines; Thiazoles | 2003 |
Synthesis and activities of oxidative metabolites of the anti-arthritic drug candidate S-2474.
Topics: Animals; Anti-Inflammatory Agents; Benzofurans; Cyclic S-Oxides; Dinoprostone; Edema; Humans; Interleukin-1; Leukotriene B4; Lipoxygenase Inhibitors; Microsomes, Liver; Rats; Thiazoles | 2003 |
Glitazones and heart failure: critical appraisal for the clinician.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Diuretics; Edema; Heart Failure; Humans; Hypoglycemic Agents; Insulin; Pioglitazone; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Synthesis and analgesic and anti-inflammatory activity of some new (6-acyl-2-benzoxazolinone and 6-acyl-2-benzothiazolinone derivatives with acetic acid and propanoic acid residues.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoxazoles; Edema; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Mice; Pain Measurement; Spectrophotometry, Infrared; Stomach Ulcer; Thiazoles | 2003 |
Synthesis and anti-inflammatory activity of alkyl/arylidene-2-aminobenzothiazoles and 1-benzothiazol-2-yl-3-chloro-4-substituted-azetidin-2-ones.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Azetidines; Carrageenan; Chemical Phenomena; Chemistry, Physical; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Edema; Female; Indicators and Reagents; Indomethacin; Isoenzymes; Male; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Rats; Stomach Ulcer; Thiazoles | 2003 |
Novel 3,3a,4,5,6,7-hexahydroindazole and arylthiazolylpyrazoline derivatives as anti-inflammatory agents.
Topics: Administration, Oral; Animals; Carrageenan; Cyclooxygenase Inhibitors; Edema; Indazoles; Male; Pyrazoles; Rats; Structure-Activity Relationship; Technology, Pharmaceutical; Thiazoles; Ulcer | 2003 |
Synthesis, characterization and antiinflammatory-analgesic properties of 6-(alpha-amino-4-chlorobenzyl)thiazolo [3,2-b]-1,2,4-triazol-5-ols.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzoquinones; Capillary Permeability; Carrageenan; Chemical Phenomena; Chemistry, Physical; Edema; Foot; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Mice; Models, Molecular; Molecular Conformation; Naproxen; Pain; Spectroscopy, Fourier Transform Infrared; Stomach Ulcer; Structure-Activity Relationship; Thiazoles; Triazoles | 2004 |
Thiazolyl and isothiazolyl azomethine derivatives with anti-inflammatory and antioxidant activities.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biphenyl Compounds; Carrageenan; Chemical Phenomena; Chemistry, Physical; Dimethyl Sulfoxide; Edema; Female; Free Radical Scavengers; Hydroxyl Radical; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred AKR; Picrates; Pregnancy; Quantitative Structure-Activity Relationship; Schiff Bases; Spectrophotometry, Infrared; Thiazoles; Thiosemicarbazones | 2004 |
Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.
Topics: Acetic Acid; Animals; Carrageenan; Central Nervous System; Constriction, Pathologic; Edema; Formaldehyde; Hyperalgesia; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain; Pain Measurement; Pain, Postoperative; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Spinal Nerves; Thiazoles; Vincristine | 2004 |
Synthesis of acridinyl-thiazolino derivatives and their evaluation for anti-inflammatory, analgesic and kinase inhibition activities.
Topics: Acridines; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoquinones; Brain; Carrageenan; CDC2 Protein Kinase; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Edema; Enzyme Inhibitors; Female; Glycogen Synthase Kinase 3; Mice; Pain Measurement; Rats; Swine; Thiazoles | 2005 |
Evaluation of anti-inflammatory and antioxidant activities of mixed-ligand Cu(II) complexes of dien and its Schiff dibases with heterocyclic aldehydes and 2-amino-2-thiazoline.
Topics: Aldehydes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carrageenan; Cations, Divalent; Copper; Edema; Free Radical Scavengers; Organometallic Compounds; Rats; Schiff Bases; Structure-Activity Relationship; Thiazoles | 2006 |
Ziprasidone-associated pedal edema in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Diuretics; Drug Hypersensitivity; Edema; Female; Foot Diseases; Humans; Immunoglobulin E; Middle Aged; Piperazines; Schizophrenia; Thiazoles | 2006 |
New isothiazole derivatives: synthesis, reactivity, physicochemical properties and pharmacological activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Carrageenan; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Edema; Erythrocyte Membrane; Female; Hindlimb; Ibuprofen; Mice; Mice, Inbred CBA; Molecular Structure; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazoles | 2006 |
2-Amino-5-thiazolyl motif: a novel scaffold for designing anti-inflammatory agents of diverse structures.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chronic Disease; Cyclooxygenase Inhibitors; Drug Design; Edema; Female; Foot; Formaldehyde; Inflammation; Male; Rats; Rats, Sprague-Dawley; Thiazoles | 2008 |
Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Bacteria; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Drug Design; Edema; Fungi; Granuloma; Humans; Male; Microbial Sensitivity Tests; Pyrazoles; Rats; Thiadiazoles; Thiazoles; Ulcer | 2008 |
In vivo and in vitro anti-inflammatory activities of alpha-linolenic acid isolated from Actinidia polygama fruits.
Topics: Acetic Acid; Actinidia; alpha-Linolenic Acid; Aminolevulinic Acid; Animals; Anti-Inflammatory Agents; Blotting, Western; Capillary Permeability; Carrageenan; Cell Line; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Edema; Enzyme Inhibitors; Fruit; Hexanes; Indicators and Reagents; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Plant Extracts; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Solvents; Tetrazolium Salts; Thiazoles | 2007 |
Thiazolyl/oxazolyl formazanyl indoles as potent anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Azo Compounds; Carrageenan; Edema; Formazans; Indoles; Molecular Structure; Rats; Structure-Activity Relationship; Thiazoles | 2008 |
Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kappaB-dependent iNOS and proinflammatory cytokines production.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Carrageenan; Cell Line; Cytokines; Densitometry; Edema; Enzyme-Linked Immunosorbent Assay; Flavanones; Glycyrrhizic Acid; Hypolipidemic Agents; Interleukin-1beta; Interleukin-6; Luciferases; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase Type II; Nitrites; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2008 |
Safe treatment of a patient with CML using dasatinib after prior retinal oedema due to imatinib.
Topics: Adult; Benzamides; Dasatinib; Edema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Retinal Diseases; Thiazoles | 2008 |
Studies on the anti-inflammatory activity and ulcerogenic adverse effect of thiazole derivatives, especially 2-amino-thiazoleacetic acid derivatives.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Edema; Erythrocytes; Hemolysis; Male; Protease Inhibitors; Protein Denaturation; Rats; Rats, Inbred Strains; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 1984 |
Synthesis and antiinflammatory activity of some new thiazole derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chromatography, Thin Layer; Edema; Indomethacin; Mice; Mice, Inbred AKR; Thiazoles | 1995 |
ABT-299, a potent antagonist of platelet activating factor.
Topics: Animals; Binding, Competitive; Blood Pressure; Edema; Esterases; Humans; Hypotension; Indoles; Kinetics; Lipopolysaccharides; Mice; Molecular Structure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Thiazoles | 1995 |
Synthesis and pharmacological properties of benzothiazole, 1,3-4-oxadiazole and 1,3,4-thiadiazole derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Benzothiazoles; Carrageenan; Edema; Lethal Dose 50; Male; Mice; Oxadiazoles; Pain Measurement; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Thiadiazoles; Thiazoles | 1994 |
S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance.
Topics: Adrenalectomy; Analgesics; Animals; Arginine; Dipyrone; Drug Tolerance; Edema; Endorphins; Fever; Hyperalgesia; Indomethacin; Male; Methylene Blue; Nitric Oxide; omega-N-Methylarginine; Pain Measurement; Rats; Rats, Wistar; Thiazoles; Yohimbine | 1995 |
Biological evaluation of compounds with -NCS- group or derived from thiazole and imidazole. Activity on prostaglandin synthetase complex.
Topics: Animals; Carrageenan; Cyclooxygenase Inhibitors; Edema; Imidazoles; Male; Peroxidases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Thiazoles | 1993 |
Synthesis and pharmacological evaluation of some 3-phenacyl-5-benzylidene-thiazolidine-2,4-diones.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Chromatography, Thin Layer; Edema; Immersion; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Rats; Seizures; Spectrophotometry, Infrared; Thiazoles | 1994 |
3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.
Topics: Administration, Oral; Animals; Capillary Permeability; Edema; In Vitro Techniques; Indoles; Magnetic Resonance Spectroscopy; Male; Mice; Platelet Activating Factor; Rabbits; Rats; Rats, Sprague-Dawley; Serotonin; Skin; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 1994 |
Synthesis, antiinflammatory and analgesic activities of some 1,2,4-thiadiazolidines and 1-4-aryl guanidines.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; Female; Guanidines; Male; Pain Measurement; Rats; Rats, Wistar; Thiazoles | 1994 |
Lipophilicity and antiinflammatory activity of some 2-(aminoacetylamino)thiazole derivatives.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemical Phenomena; Chemistry, Physical; Chromatography, Thin Layer; Edema; Lipids; Male; Mice; Pain Measurement; Rats; Rats, Wistar; Thiazoles | 1993 |
3,3'-Bi-[1,3-thiazolidine-4-one] system. VII. Synthesis and SARS of some 2-heteroaryl derivatives with antiinflammatory and related activities.
Topics: Acetates; Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Edema; Magnetic Resonance Spectroscopy; Male; Mice; Pain; Pain Measurement; Rats; Rats, Wistar; Spectrophotometry, Infrared; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 1994 |
Anti-inflammatory activity of an orally active peptide sequence from PF-4 on acute inflammation and DTH.
Topics: Aldehyde Reductase; Amino Acid Sequence; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Edema; Enzyme Inhibitors; Female; Hypersensitivity, Delayed; Inflammation; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Prednisone; Thiazoles; Thiazolidinediones | 1995 |
Effect of KBT-3022, a new diphenylthiazole derivative, on platelet functions.
Topics: Adenosine Diphosphate; Administration, Oral; Animals; Arachidonic Acid; Aspirin; Blood Platelets; Collagen; Edema; Erythema; Gastric Mucosa; Guinea Pigs; Humans; Mice; Platelet Aggregation Inhibitors; Pyrroles; Rabbits; Rats; Serotonin; Species Specificity; Thiazoles; Thrombin; Ultraviolet Rays | 1995 |
Synthesis and SAR study of imidazo[2,1-b]benzothiazole acids and some related compounds with anti-inflammatory and analgesic activities.
Topics: Acetates; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Edema; Female; Imidazoles; Pain; Pain Measurement; Pregnancy; Rats; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 1996 |
In the search for new antiinflammatory drugs: synthesis and antiinflammatory activity of some Thiazolo(3,2-a)pyrimidine derivatives containing a thioether group.
Topics: Alkylation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Edema; Female; Male; Pyrimidines; Rats; Rats, Wistar; Thiazoles | 1995 |
Anti-inflammatory activity of some novel 1-[3-(aroylo)] and one 1-[3-(aryloxy)]-propyl aminothiazole in correlation with structure and lipophilicity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Behavior, Animal; Bepridil; Biphenyl Compounds; Carrageenan; Chromatography, Thin Layer; Edema; Free Radicals; Glucuronidase; Male; Mice; Mice, Inbred AKR; Picrates; Structure-Activity Relationship; Thiazoles | 1996 |
The therapeutic effect of C1-inhibitor on gut-derived bacterial translocation after thermal injury.
Topics: Animals; Bacterial Translocation; Body Weight; Burns; Complement C1 Inactivator Proteins; Complement Membrane Attack Complex; Complement System Proteins; Digestive System; Edema; Feces; Glycoproteins; Hemodynamics; Kidney; Liver; Lung; Lymph Nodes; Male; Skin; Swine; Tetrazolium Salts; Thiazoles | 1998 |
Thiazolyl and benzothiazolyl Schiff bases as novel possible lipoxygenase inhibitors and anti inflammatory agents. Synthesis and biological evaluation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemical Phenomena; Chemistry, Physical; Edema; Female; Foot; Free Radical Scavengers; Glycine max; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred A; Mice, Inbred AKR; Schiff Bases; Superoxides; Thiazoles | 1998 |
New thiazolidones-4 with pyrazolone-5 substituent as the potential NSAIDs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Edema; Pyrazoles; Pyrazolones; Rats; Structure-Activity Relationship; Thiazoles | 1998 |
Condensed heterocyclic compounds: synthesis and antiinflammatory activity of novel thiazolo[3,2-alpha] pyrimidines.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Edema; Female; Heterocyclic Compounds; Hindlimb; Male; Mice; Pyrimidines; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 1998 |
Synthesis and biological activity of novel thiazolidinediones.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Butanones; Chromans; Edema; Female; Hypoglycemic Agents; Male; Mice; Nabumetone; Rats; Rats, Wistar; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
Significant weight gain with rezulin therapy.
Topics: Chromans; Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Male; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 1999 |
Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Gastric Mucosa; Humans; Hyperalgesia; Isoenzymes; Male; Membrane Proteins; Mice; Oxazoles; Phenols; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 1999 |
Synthesis and anti-inflammatory and analgesic activities of 2,4-di-n-butyl-3,5-diarylimino-1,2,4-thiadiazolidines.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; Female; Male; Pain Measurement; Rats; Thiazoles | 1991 |
Synthesis and evaluation of anti-inflammatory activity of some thiazolo[3,2-b]-1,2,4-triazole-5(6H)-ones and their Michael addition products.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Edema; Female; Magnetic Resonance Spectroscopy; Male; Mice; Stomach Ulcer; Thiazoles; Triazoles | 1999 |
General pharmacological properties of YJA 20379-1, a novel proton pump inhibitor with antiulcer activities.
Topics: Analgesics; Animals; Anti-Ulcer Agents; Anticonvulsants; Autonomic Nervous System; Behavior, Animal; Benzothiazoles; Body Temperature; Diuretics; Edema; Enzyme Inhibitors; Female; Gastrointestinal Transit; Guinea Pigs; Hemodynamics; Imidazoles; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Motor Activity; Muscle, Smooth; Proton Pump Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Respiratory Mechanics; Thiazoles | 1999 |
Synthesis of some new thienyl and 1,3-thiazolyl-aminoketones with anti-inflammatory activity.
Topics: Amines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bepridil; Biphenyl Compounds; Carrageenan; Chemical Phenomena; Chemistry, Physical; Dimethyl Sulfoxide; Edema; Female; Free Radical Scavengers; Free Radicals; Hydroxyl Radical; Ketones; Male; Mice; Mice, Inbred AKR; Picrates; Structure-Activity Relationship; Superoxides; Thiazoles; Trypsin Inhibitors | 2000 |
Clinical characteristics of pramipexole-induced peripheral edema.
Topics: Adult; Aged; Aged, 80 and over; Benzothiazoles; Dopamine Agonists; Edema; Female; Humans; Male; Middle Aged; Parkinsonian Disorders; Peripheral Nervous System Diseases; Pramipexole; Retrospective Studies; Severity of Illness Index; Thiazoles | 2000 |
Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide (gamma-sultam) skeleton: cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Blood Platelets; Cyclic S-Oxides; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Female; Gastric Mucosa; Humans; Interleukin-1; Isoenzymes; Leukotriene B4; Lipoxygenase Inhibitors; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Structure-Activity Relationship; Synovial Membrane; Thiazoles | 2000 |
Synthesis of 6,7-dialkoxy-2-arylmethylidene-2,3- dihydrobenzo[4,5]imidazo[2,1-b][1,3]thiazol-3-ones exhibiting anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bentonite; Carrageenan; Chemical Phenomena; Chemistry, Physical; Edema; Imidazoles; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred BALB C; Rats; Rats, Wistar; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Thiazoles | 2000 |
Synthesis of new [1,3,4]thiadiazolo[3,2-a]thieno[2,3-d]pyrimidinone derivatives with antiinflammatory activity.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Chemistry, Physical; Edema; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Pain Measurement; Peritonitis; Pyrimidinones; Rats; Spectrophotometry, Infrared; Stomach Ulcer; Thiazoles | 2000 |
Synthesis of some thiazolo[3,2-b]-1,2,4-triazole-5(6H)-ones and their novel Michael addition products with anti-inflammatory activities.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemical Phenomena; Chemistry, Physical; Edema; Female; Magnetic Resonance Spectroscopy; Male; Mice; Spectrophotometry, Infrared; Stomach Ulcer; Thiazoles; Triazoles | 2001 |
3-Arylsulphonyl-5-arylamino-1,3,4-thiadiazol-2(3H)ones as anti-inflammatory and analgesic agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Edema; Female; Male; Mice; Pain; Rats; Sulfur Compounds; Thiazoles | 2001 |
Synthesis and pharmacological activities of some new 2-[1-(6-methoxy-2-naphthyl)ethyl]-6-(substituted)benzylidene thiazolo[3,2-b]-1,2,4-triazole-5(6H)-one derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chromatography, Thin Layer; Cyclization; Edema; Female; Gastric Mucosa; Male; Mice; Naphthalenes; Naproxen; Stomach Ulcer; Thiazoles | 2001 |
Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Platelets; Cyclooxygenase Inhibitors; Drug Screening Assays, Antitumor; Ear, External; Edema; Female; Foot; Humans; Hypersensitivity, Delayed; In Vitro Techniques; Inflammation; Leukotriene B4; Leukotrienes; Mice; Neutrophils; Oleanolic Acid; Oxidation-Reduction; Peroxidase; Pistacia; Rats; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Triterpenes | 2001 |
Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis.
Topics: Adjuvants, Immunologic; Animals; Arthritis, Experimental; Chronic Disease; Collagen; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Edema; Female; Hindlimb; Isoenzymes; Membrane Proteins; Piperazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Thiazoles; Thromboxane B2 | 2002 |
Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes.
Topics: Adult; Aged; Body Mass Index; Body Weight; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Obesity; Rosiglitazone; Thiazoles; Thiazolidinediones | 2002 |
Potentiative effects of sulfhydryl compounds on carrageenin-induced oedema in rats and relationship to their potencies as inhibitors of angiostin-coverting enzyme in vivo.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carrageenan; Dose-Response Relationship, Drug; Drug Synergism; Edema; Male; Rats; Sulfhydryl Compounds; Thiazoles | 1978 |
[Anti-edematous, anti-inflammatory and analgesics activity of fentiazac, naproxen and diclofenac sodium].
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Edema; Mice; Naproxen; Peritonitis; Phenylacetates; Pleurisy; Rats; Thiazoles | 1977 |
Substituted oxothiazolyl acetic acids as antiinflammatory agents.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Carrageenan; Edema; Lethal Dose 50; Rats; Thiazoles | 1978 |
[Elkapin--a new diuretic and antihypertensive agent].
Topics: Antihypertensive Agents; Diuretics; Edema; Female; Humans; Hypertension; Male; Piperidines; Thiazoles | 1978 |
Antiinflammatory and antiproteolytic properties of substituted-4-thiazolidones.
Topics: Animals; Anti-Inflammatory Agents; Edema; Lethal Dose 50; Mice; Rats; Serum Albumin, Bovine; Structure-Activity Relationship; Thiazoles; Trypsin Inhibitors | 1977 |
[Anti-inflammatory and analgesic activity of a new synthetic molecule: 2-phenyl-4-p-chlorophenyl-thiazole-5-yl-acetic acid].
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Edema; Hindlimb; Rats; Thiazoles | 1975 |
Synthesis and anti-inflammatory activity of 2-pyridyl-2-thiobenzothiazole derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cattle; Dinoprostone; Edema; Free Radicals; Humans; In Vitro Techniques; Indomethacin; Male; Rats; Rats, Wistar; Synovial Fluid; Thiazoles | 1992 |
Synthesis of carboxyalkylthio-triazoles and bicyclic derivatives with antiinflammatory and analgesic activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Carrageenan; Edema; Lethal Dose 50; Mice; Pain Measurement; Rats; Structure-Activity Relationship; Superoxides; Thiazoles; Triazoles | 1992 |
4-(1,2-Benzisothiazol-3-yl)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Edema; Escherichia coli; Ibuprofen; Male; Mice; Pain; Phenylbutazone; Pyrogens; Rats; Rats, Wistar; Thiazoles | 1992 |
Effect of SR 27417 on oedema formation induced in rabbit skin by platelet-activating factor or antigen.
Topics: Allergens; Animals; Antigens; Edema; Injections, Intravenous; Male; Ovalbumin; Platelet Activating Factor; Rabbits; Skin Diseases; Thiazoles | 1992 |
Bis basic substituted diaminobenzobisthiazoles as potential antiarthritic agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Edema; Hemolytic Plaque Technique; Male; Mice; Mice, Inbred AKR; Molecular Structure; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thiazoles | 1992 |
The effect of photosensitive dye platonin on juvenile rheumatoid arthritis.
Topics: Adolescent; Arthritis, Juvenile; Blood Cell Count; Child, Preschool; Coloring Agents; Edema; Female; Humans; Prednisolone; Thiazoles | 1991 |
Synthesis and pharmacological activity of 6H-thiazolo [3',2': 1,2]-5-oxopyrimido[5,4-b]indole derivatives, a new heterocyclic ring system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Carrageenan; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Edema; Exudates and Transudates; Indoles; Lethal Dose 50; Male; Mice; Psychomotor Performance; Pyrimidines; Rats; Rats, Inbred Strains; Stomach Ulcer; Thiazoles | 1990 |
Biological activity of the main metabolites of meloxicam.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Edema; Exudates and Transudates; Kaolin; Male; Meloxicam; Prostaglandins; Rats; Thiazines; Thiazoles | 1990 |
Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis, Leukocyte; Cyclophosphamide; Dinoprostone; Ear Diseases; Edema; Eicosanoids; Imidazoles; Inflammation; Leukotriene B4; Male; Mice; Mice, Inbred BALB C; Neutrophils; Peritonitis; Pyridines; Thiazoles | 1989 |
Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase.
Topics: Administration, Oral; Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cyclooxygenase Inhibitors; Edema; Imidazoles; Lipoxygenase Inhibitors; Male; Rats; Rats, Inbred Lew; Thiazoles | 1987 |
Novel thiazolidinones as potent anti-inflammatory and analgesic agents.
Topics: Aconitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemical Phenomena; Chemistry; Edema; Female; Gossypium; Lethal Dose 50; Male; Mice; Rats; Stomach Ulcer; Thiazoles | 1985 |
Anti-inflammatory activity of a dual inhibitor of cyclooxygenase and lipoxygenase pathways, CBS-1108 (2-acetylthiophene-2-thiazolylhydrazone).
Topics: Animals; Anti-Inflammatory Agents; Aqueous Humor; Cell Movement; Croton Oil; Cyclooxygenase Inhibitors; Edema; Eye Proteins; Leukocytes; Lipoxygenase Inhibitors; Male; Mast Cells; Rabbits; Serotonin; Thiazoles | 1985 |
On the anti-inflammatory properties of the schistosomicide niridazole (Ambilhar).
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents; Arthritis; Disease Models, Animal; Dracunculiasis; Edema; Imidazoles; Kaolin; Niridazole; Pleurisy; Rats; Thiazoles; Turpentine | 1971 |
[Biological properties of 1,2-benzisothiazoles compounds. Anti-inflammatory and antihistaminic activity of 3-alkylaminoalkoxybenzisothizoles].
Topics: Animals; Anti-Inflammatory Agents; Benzoxazoles; Chemical Phenomena; Chemistry; Edema; Guinea Pigs; Histamine H1 Antagonists; Rats; Thiazoles | 1969 |
Nonsteroidal antiinflammatory agents. 1.2,4-Diphenylthiazole-5-acetic acid and related compounds.
Topics: Acetates; Albumins; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzaldehydes; Bradykinin; Carrageenan; Edema; Freund's Adjuvant; Guinea Pigs; Indomethacin; Nitrobenzenes; Phenylbutazone; Protein Binding; Protein Denaturation; Rats; Structure-Activity Relationship; Thiazoles | 1974 |
The preparation and pharmacological selection of a new anti-inflammatory agent, thiazolinobutazone.
Topics: Animals; Carrageenan; Cats; Drug Evaluation, Preclinical; Edema; Female; Hypertension; Male; Mice; Peptic Ulcer; Phenylbutazone; Rats; Thiazoles | 1974 |
Pharmacological properties of thiazolinobutazone (LAS 11871). I. Anti-inflammatory effects.
Topics: Abscess; Administration, Oral; Adrenalectomy; Animals; Bradykinin; Bronchial Spasm; Carrageenan; Edema; Erythema; Female; Granuloma; Guinea Pigs; Injections, Intravenous; Injections, Subcutaneous; Male; Phenylbutazone; Rats; Thiazoles; Ultraviolet Rays | 1974 |
Sudoxicam and related N-heterocyclic carboxamides of 4-hydroxy-2H-1,2-benzothiazine 1,1-dioxide. Potent nonsteroidal antiinflammatory agents.
Topics: Administration, Oral; Adrenalectomy; Amides; Animals; Anti-Inflammatory Agents; Arthritis; Carrageenan; Dogs; Edema; Erythema; Foot; Guinea Pigs; Half-Life; Haplorhini; Mice; Rats; Thiazines; Thiazoles | 1972 |
[Comparative study on the efficiency of new antiphlogistics].
Topics: Acetates; Aniline Compounds; Animals; Anti-Inflammatory Agents; Autolysis; Chlorine; Edema; Evaluation Studies as Topic; Hydroxamic Acids; Indazoles; Indoles; Malonates; Nicotinic Acids; ortho-Aminobenzoates; Phenothiazines; Phenylacetates; Propionates; Proteins; Pyridazines; Rats; Thiazoles; Toluene; Triazines | 1972 |
A new nonsteroidal antiinflammatory agent. 2-Substituted 5- or 6-benzothiazoleacetic acids and their derivatives.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Carrageenan; Edema; Foot; Lethal Dose 50; Male; Rats; Structure-Activity Relationship; Thiazoles | 1973 |
A new nonsteroidal antiinflammatory agent. 3. Analogs of 2-substituted 5-benzothiazoleacetic acids and their derivatives.
Topics: Acetates; Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Edema; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Motor Activity; Phenylbutazone; Rats; Structure-Activity Relationship; Thiazoles | 1974 |
[Letter: Hyperthyroidism and amiodarone].
Topics: Antihypertensive Agents; Benzofurans; Edema; Humans; Hyperthyroidism; Male; Middle Aged; Thiazoles | 1974 |
[Anti-inflammatory and analgesic action of 2-phenyl-5-benzothiazole acetic acid (K-308) and 2-phenyl-5-benzothiazole propionic acid (K-309)].
Topics: Adrenal Glands; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Capillary Permeability; Edema; Erythema; Female; Gastric Mucosa; Granuloma; Hemolysis; Histamine Antagonists; Hot Temperature; Mice; Organ Size; Phenylpropionates; Protein Denaturation; Rabbits; Rats; Thiazoles; Thymus Gland | 1974 |
[Analgesic, antipyretic and antiphlogistic effect of several new acids of the phenylethylene-thiazole series].
Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents; Body Temperature; Edema; Fever; Inflammation; Rats; Styrenes; Thiazoles | 1972 |
2-Phenyl-4H-cyclopentathiazole-4-carboxylic acids as potential antiinflammatory agents.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Carboxylic Acids; Carrageenan; Cyclopentanes; Edema; Erythema; Guinea Pigs; Infrared Rays; Magnetic Resonance Spectroscopy; Rats; Spectrum Analysis; Thiazoles; Ultraviolet Rays | 1972 |
Pharmacological investigations of benzothiazoline derivatives.
Topics: Amines; Analgesics; Animals; Anti-Inflammatory Agents; Benzyl Compounds; Body Temperature; Carrageenan; Edema; Formaldehyde; Guinea Pigs; Lethal Dose 50; Male; Methylamines; Ovalbumin; Oxyphenbutazone; Phenylbutazone; Piperazines; Pyrazoles; Rats; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 1972 |
Anti-inflammatory activity of tiaramide hydrochloride, 4-((5-chloro-2-oxo-3-benzothiazolinyl)acetyl)-1-piperazine ethanol hydrochloride.
Topics: Animals; Anti-Inflammatory Agents; Benzyl Compounds; Capillary Permeability; Edema; Ethanol; Female; Granulation Tissue; Granuloma; Guinea Pigs; Hemolysis; Male; Methylamines; Mice; Piperazines; Pyrazoles; Rats; Serum Albumin, Bovine; Thiazoles; Thymus Gland; Wound Healing | 1972 |
Diaryloxazole and diarylthiazolealkanoic acids: two novel series of non-steroidal anti-inflammatory agents.
Topics: Aldehydes; Animals; Anti-Inflammatory Agents; Aspirin; Biological Assay; Carrageenan; Edema; Gastric Mucosa; Gastrointestinal Hemorrhage; Hot Temperature; Humans; Indomethacin; Oxazoles; Phenylbutazone; Protein Denaturation; Rats; Serum Albumin; Thiazoles | 1968 |
N-Gamma-dimethylaminopropyl-1,2-benzisothiazolone (Bu-310) an anti-inflammatory agent.
Topics: Analgesics; Anesthesia; Animals; Anti-Inflammatory Agents; Anticonvulsants; Antitussive Agents; Body Temperature; Body Weight; Cardiovascular System; Dextrans; Dogs; Edema; Granuloma; Hydrocortisone; Hypophysectomy; Rats; Respiratory System; Thiazoles | 1968 |